Natl. Plywood (516062)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Tiny absolute scale: ₹18 Cr market cap and ₹2 Cr quarterly sales mean even a modest recovery in revenue could have a large percentage impact.
• Quarterly net loss of ₹1 Cr is small in absolute terms, so breakeven is plausibly achievable with cost control or a sales uptick.
• Current price ₹5.07 is above the 52-week low of ₹1.65, indicating some recovery in investor sentiment from the worst levels.
• Zero dividend payout means cash is not being distributed while the company attempts to stabilise operations.

Concerns

• Sales growth of -79.37% and quarterly sales of only ₹2 Cr indicate severe demand destruction.
• Latest quarter net loss of ₹1 Cr on sales of ₹2 Cr implies a very poor operating margin that cannot be sustained indefinitely.
• Piotroski F-Score of 2/9 and ROCE of 0.00% signal weak financial health and no return on invested capital.
• Missing book value, P/B, debt/equity, and promoter holding data make any asset-based margin of safety impossible to calculate.

AI Analysis

At first glance, this is exactly the kind of stock Benjamin Graham would call speculative, not investment. Natl. Plywood has a market cap of only ₹18 Cr, but there is no usable earning power. Sales have fallen 79.37%, profit growth has swung by -184.62%, and the latest quarter shows just ₹2 Cr of revenue and a ₹1 Cr net loss. With P/E at 0.00 and ROCE at 0.00%, the business is not generating a return on the capital it employs. The Piotroski F-Score of 2/9 is a red flag: the company fails on most fundamental health tests. I also have no book value or debt-to-equity number to work with. In my circle of competence, if I cannot see the balance sheet or determine asset backing, I cannot calculate any margin of safety. The absence of a dividend means shareholders get nothing while they wait for recovery. On the positive side, the absolute loss is not enormous: ₹1 Cr in the latest quarter. A relatively small improvement in sales or costs could bring the company to breakeven, and the stock has traded as high as ₹6.36, above today's ₹5.07. That shows the market is not entirely broken. But a rising stock price is not a business fact. The 79% sales collapse tells me the underlying business is severely damaged. Market cap of ₹18 Cr against an annualized run-rate of roughly ₹8 Cr in sales is not obviously cheap. Without reliable book value, I cannot call this an asset play. This is a speculative turnaround at best. I need evidence of stabilised demand and a credible path to positive earnings. Until then, this goes in the too-hard pile.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer